Wakamoto Pharmaceutical Co.,Ltd. (4512.T)
JPY 332.0
(0.91%)
JPY 332.0
(0.91%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 15.42 Billion JPY | -1.85% |
| 2022 | 15.71 Billion JPY | 5.07% |
| 2021 | 14.95 Billion JPY | 2.61% |
| 2020 | 14.57 Billion JPY | -8.83% |
| 2019 | 15.98 Billion JPY | -10.02% |
| 2018 | 17.76 Billion JPY | -1.06% |
| 2017 | 17.95 Billion JPY | 0.37% |
| 2016 | 17.88 Billion JPY | -2.16% |
| 2015 | 18.28 Billion JPY | -3.63% |
| 2014 | 18.97 Billion JPY | -4.64% |
| 2013 | 19.89 Billion JPY | 13.34% |
| 2012 | 17.55 Billion JPY | 4.17% |
| 2011 | 16.84 Billion JPY | -1.91% |
| 2010 | 17.17 Billion JPY | -2.98% |
| 2009 | 17.7 Billion JPY | -0.22% |
| 2008 | 17.74 Billion JPY | 3.66% |
| 2007 | 17.11 Billion JPY | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 15.43 Billion JPY | 0.12% |
| 2023 Q3 | 15.25 Billion JPY | -3.52% |
| 2023 Q4 | 15.42 Billion JPY | 1.09% |
| 2023 Q1 | 15.5 Billion JPY | -1.3% |
| 2023 FY | 15.42 Billion JPY | -1.85% |
| 2023 Q2 | 15.81 Billion JPY | 1.96% |
| 2022 Q1 | 14.8 Billion JPY | -0.99% |
| 2022 FY | 15.71 Billion JPY | 5.07% |
| 2022 Q4 | 15.71 Billion JPY | 3.75% |
| 2022 Q3 | 15.14 Billion JPY | 2.75% |
| 2022 Q2 | 14.73 Billion JPY | -0.46% |
| 2021 Q2 | 14.71 Billion JPY | 1.46% |
| 2021 Q4 | 14.95 Billion JPY | 1.79% |
| 2021 Q3 | 14.69 Billion JPY | -0.18% |
| 2021 FY | 14.95 Billion JPY | 2.61% |
| 2021 Q1 | 14.5 Billion JPY | -0.46% |
| 2020 Q4 | 14.57 Billion JPY | 0.14% |
| 2020 Q1 | 15.93 Billion JPY | -0.33% |
| 2020 Q2 | 14.99 Billion JPY | -5.87% |
| 2020 Q3 | 14.55 Billion JPY | -2.96% |
| 2020 FY | 14.57 Billion JPY | -8.83% |
| 2019 Q4 | 15.98 Billion JPY | -3.57% |
| 2019 FY | 15.98 Billion JPY | -10.02% |
| 2019 Q3 | 16.57 Billion JPY | 2.98% |
| 2019 Q2 | 16.09 Billion JPY | -6.32% |
| 2019 Q1 | 17.18 Billion JPY | -3.29% |
| 2018 Q3 | 17.76 Billion JPY | -2.15% |
| 2018 FY | 17.76 Billion JPY | -1.06% |
| 2018 Q4 | 17.76 Billion JPY | -0.03% |
| 2018 Q2 | 18.15 Billion JPY | 0.54% |
| 2018 Q1 | 18.06 Billion JPY | 0.59% |
| 2017 Q4 | 17.95 Billion JPY | -2.44% |
| 2017 FY | 17.95 Billion JPY | 0.37% |
| 2017 Q3 | 18.4 Billion JPY | 2.92% |
| 2017 Q2 | 17.88 Billion JPY | -1.47% |
| 2017 Q1 | 18.14 Billion JPY | 1.46% |
| 2016 Q1 | 18.03 Billion JPY | -1.35% |
| 2016 FY | 17.88 Billion JPY | -2.16% |
| 2016 Q4 | 17.88 Billion JPY | 0.86% |
| 2016 Q3 | 17.73 Billion JPY | 0.32% |
| 2016 Q2 | 17.68 Billion JPY | -1.98% |
| 2015 Q2 | 18.57 Billion JPY | -1.47% |
| 2015 FY | 18.28 Billion JPY | -3.63% |
| 2015 Q4 | 18.28 Billion JPY | -4.47% |
| 2015 Q1 | 18.85 Billion JPY | -0.64% |
| 2015 Q3 | 19.13 Billion JPY | 3.04% |
| 2014 FY | 18.97 Billion JPY | -4.64% |
| 2014 Q2 | 18.75 Billion JPY | -1.51% |
| 2014 Q4 | 18.97 Billion JPY | -0.27% |
| 2014 Q3 | 19.02 Billion JPY | 1.42% |
| 2014 Q1 | 19.04 Billion JPY | -4.27% |
| 2013 Q2 | 17.28 Billion JPY | -2.66% |
| 2013 Q3 | 17.74 Billion JPY | 2.63% |
| 2013 Q4 | 19.89 Billion JPY | 12.12% |
| 2013 FY | 19.89 Billion JPY | 13.34% |
| 2013 Q1 | 17.76 Billion JPY | 1.19% |
| 2012 Q3 | 16.78 Billion JPY | 0.51% |
| 2012 Q4 | 17.55 Billion JPY | 4.6% |
| 2012 Q2 | 16.69 Billion JPY | -0.94% |
| 2012 FY | 17.55 Billion JPY | 4.17% |
| 2012 Q1 | 16.85 Billion JPY | 0.02% |
| 2011 Q2 | 17.26 Billion JPY | 0.04% |
| 2011 FY | 16.84 Billion JPY | -1.91% |
| 2011 Q3 | 16.92 Billion JPY | -1.94% |
| 2011 Q1 | 17.25 Billion JPY | 0.46% |
| 2011 Q4 | 16.84 Billion JPY | -0.46% |
| 2010 Q4 | 17.17 Billion JPY | -0.88% |
| 2010 FY | 17.17 Billion JPY | -2.98% |
| 2010 Q1 | 17.7 Billion JPY | 0.02% |
| 2010 Q2 | 17.43 Billion JPY | -1.55% |
| 2010 Q3 | 17.32 Billion JPY | -0.6% |
| 2009 Q4 | 17.7 Billion JPY | -0.8% |
| 2009 Q3 | 17.84 Billion JPY | -6.22% |
| 2009 Q2 | 19.03 Billion JPY | 0.0% |
| 2009 FY | 17.7 Billion JPY | -0.22% |
| 2008 Q3 | 18.05 Billion JPY | 0.0% |
| 2008 Q4 | 17.74 Billion JPY | -1.7% |
| 2008 FY | 17.74 Billion JPY | 3.66% |
| 2007 FY | 17.11 Billion JPY | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Pharma Foods International Co., Ltd. | 36.57 Billion JPY | 57.835% |
| Takeda Pharmaceutical Company Limited | 15108.79 Billion JPY | 99.898% |
| Sumitomo Pharma Co., Ltd. | 907.5 Billion JPY | 98.301% |
| Shionogi & Co., Ltd. | 1416.91 Billion JPY | 98.912% |
| Nippon Shinyaku Co., Ltd. | 263.4 Billion JPY | 94.145% |
| Kaken Pharmaceutical Co., Ltd. | 171.62 Billion JPY | 91.015% |
| Eisai Co., Ltd. | 1393.79 Billion JPY | 98.894% |
| Morishita Jintan Co., Ltd. | 17.18 Billion JPY | 10.254% |
| Hisamitsu Pharmaceutical Co., Inc. | 328.77 Billion JPY | 95.31% |
| Mochida Pharmaceutical Co., Ltd. | 158.8 Billion JPY | 90.289% |
| Fuso Pharmaceutical Industries,Ltd. | 76.46 Billion JPY | 79.831% |
| Nippon Chemiphar Co., Ltd. | 49.54 Billion JPY | 68.877% |
| Tsumura & Co. | 428.25 Billion JPY | 96.399% |
| Kissei Pharmaceutical Co., Ltd. | 260.92 Billion JPY | 94.09% |
| Torii Pharmaceutical Co., Ltd. | 133.43 Billion JPY | 88.443% |
| Towa Pharmaceutical Co., Ltd. | 430.65 Billion JPY | 96.419% |
| Fuji Pharma Co., Ltd. | 85.33 Billion JPY | 81.928% |
| Zeria Pharmaceutical Co., Ltd. | 150.53 Billion JPY | 89.756% |
| KYORIN Holdings, Inc. | 177.67 Billion JPY | 91.321% |
| Taiko Pharmaceutical Co.,Ltd. | 15.04 Billion JPY | -2.493% |
| Daito Pharmaceutical Co.,Ltd. | 77.7 Billion JPY | 80.155% |
| SymBio Pharmaceuticals Limited | 15.35 Billion JPY | -0.45% |
| MedRx Co., Ltd | 2.05 Billion JPY | -651.513% |
| Mizuho Medy Co.,Ltd. | 18.94 Billion JPY | 18.615% |
| Solasia Pharma K.K. | 2.55 Billion JPY | -504.747% |
| Modalis Therapeutics Corporation | 2.02 Billion JPY | -661.186% |
| ASKA Pharmaceutical Holdings Co.,Ltd. | 93.31 Billion JPY | 83.474% |
| Sawai Group Holdings Co., Ltd. | 382.02 Billion JPY | 95.963% |
| Cyfuse Biomedical K.K. | 4.21 Billion JPY | -265.878% |
| Toho Holdings Co., Ltd. | 773.42 Billion JPY | 98.006% |
| Koa Shoji Holdings Co.,Ltd. | 32 Billion JPY | 51.815% |